BLFS vs STVN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BLFS · BioLife Solutions$0.00 ▲ 0.00%
STVN · Stevanato Group$13.57 ▲ 2.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BLFS +46.9%
- STVN -19.5%
Head to head
| Metric | BLFS | STVN |
|---|---|---|
| Price | $0.00 | $13.57 |
| Change today | ▲ 0.00% | ▲ 2.73% |
| Market cap | $1.89B | $3.71B |
| Return, 3 months | +42.0% | -34.1% |
| Return, year to date | +59.7% | -32.3% |
| Return, 1 year | +46.8% | -43.5% |
| P/E (TTM) | 32.7 | 23.7 |
| P/B | 4.5 | 2.1 |
| P/E percentile vs own 5y | 92nd | 43rd |
| Dividend yield | – | 0.45% |
| Revenue growth (YoY, latest qtr) | +21.5% | +7.8% |
| Net profit growth (YoY) | +384.8% | -22.7% |
| Gross margin | 63.6% | 29.2% |
| Operating margin | 1.6% | 17.4% |
| Net margin | 54.3% | 11.0% |
| Return on equity | 15.1% | 9.1% |
| Analyst target vs. price | – | +71.3% |
| Analyst buy share | 0% | 67% |
| RSI (14) | 61 | 23 |
| 30-day volatility | 30.6% | 102.2% |
| Max drawdown, 1 year | -37.0% | -49.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- STVN is the largest of the group by market value.
- BLFS has returned the most over the past year.
- STVN carries the lowest trailing P/E.
- BLFS is growing revenue fastest.
- BLFS keeps the most profit per dollar of sales.
- BLFS has been the calmest stock over the last 30 days.